Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
The percentage of prostate cancer patients with positive lymph nodes increased from 2.4% in 2010 to 4.7% in 2014. The following article is part of conference coverage from the 2018 American Urological ...
Study findings have implications for biopsy-free radical prostatectomy. Combining PSMA-PET and mpMRI results to diagnose clinically significant prostate cancer while excluding benign prostatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback